Sequential changes in beta-cell function in insulin-treated diabetic patients assessed by C-peptide immunoreactivity.
D000328:Adult; D000941:Antigens; D001786:Blood Glucose / Q000032:analysis; D002648:Child; D003920:Diabetes Mellitus / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism*; D003922:Diabetes Mellitus, Type 1 / Q000378:metabolism; D016883:Diabetic Ketoacidosis / Q000097:blood; D005951:Glucose Tolerance Test; D006801:Humans; D006943:Hyperglycemia / Q000097:blood; D007118:Immunoassay; D007328:Insulin / Q000096:biosynthesis / Q000097:blood / Q000627:therapeutic use; D007330:Insulin Antibodies; D007515:Islets of Langerhans / Q000166:cytology / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000097:blood*; D012075:Remission, Spontaneous
D000941:Antigens; D001786:Blood Glucose; D007328:Insulin; D007330:Insulin Antibodies; D010455:Peptides